Home > Cashflow Statement > MANKIND PHARMA

MANKIND PHARMA
Cash Flow from Operating Activities

    Back to Cashflow Statement
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
AD     Remove this Ad

MANKIND PHARMA Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹2,413 Cr₹2,152 Cr₹1,813 Cr₹920 Cr₹1,137 Cr

What is the latest Cash Flow from Operating Activities ratio of MANKIND PHARMA ?

The latest Cash Flow from Operating Activities ratio of MANKIND PHARMA is ₹2,413 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹2,413 Cr
Mar2024₹2,152 Cr
Mar2023₹1,813 Cr
Mar2022₹920 Cr
Mar2021₹1,137 Cr

How is Cash Flow from Operating Activities of MANKIND PHARMA Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹2,413 Cr
12.12
Mar2024 ₹2,152 Cr
18.70
Mar2023 ₹1,813 Cr
97.15
Mar2022 ₹920 Cr
-19.12
Mar2021 ₹1,137 Cr -

Compare Cash Flow from Operating Activities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹79,358.7 Cr -7% -5.7% -6.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,407.0 Cr -2.2% 2.5% 1.7% Stock Analytics
DIVIS LABORATORIES ₹159,596.0 Cr -1.2% -4.5% 5.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,619.0 Cr -2.1% -0.2% 36.1% Stock Analytics
DR REDDYS LABORATORIES ₹104,544.0 Cr -2.4% -2.1% 11.5% Stock Analytics
CIPLA ₹98,767.6 Cr -4.6% -8% -16.8% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-7%

-5.7%

-6.8%

SENSEX

-3.7%

-13.2%

-2%


You may also like the below Video Courses